Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Vehicle-controlled, Multicenter, Multinational, Parallel-group Study of the Efficacy and Safety of ZK245186 Ointment in Concentrations of 0.01, 0.03, and 0.1% Over 4 Weeks in Patients With Atopic Dermatitis (AD)

NCT01228513 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01228513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01228513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Vehicle-controlled, Multicenter, Multinational, Parallel-group Study of the Efficacy and Safety of ZK245186 Ointment in Concentrations of 0.01, 0.03, and 0.1% Over 4 Weeks in Patients With Atopic Dermatitis (AD)
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2010
Completion date
April 30, 2012
Enrollment
263 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis